Search

everythinglearnresearchcommunity

for

Search:↓

A new system helps better diagnose and treat female androgenization conditions like PCOS.

Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.

Metformin should be used for PCOS mainly in those with glucose intolerance, and has limited benefits for infertility or hirsutism.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

PCOS has a strong genetic basis, but more research is needed to fully understand it.

A woman's severe hirsutism was caused by Leydig cell tumors in her ovaries, which improved after surgery.

PCOS may have evolved as an advantage in past environments with food scarcity.

The research suggests that the ZP4 gene is linked to egg development in women with PCOS but requires more study to understand its role in infertility.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Adolescent females with PCOS have higher serum cystatin C levels, indicating potential metabolic and cardiovascular issues.

New treatments like PBMC, G-CSF, and PRP show promise for helping with repeated implantation failure.

Women with PCOS often have sleep problems, including sleep apnea, which are linked to obesity and depression.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Coping skills in PCOS patients don't significantly affect mental health, quality of life, or body weight.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

There's no significant link between the D19S884 marker at the insulin receptor gene and polycystic ovary syndrome.

Quercetin may help with PCOS symptoms, but more research is needed.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.